Загрузка...
Factor VIII inhibitors in hemophilia A: rationale and latest evidence
Factor VIII (FVIII) replacement therapy is the foundation of treatment in hemophilia A and is effective unless a patient develops an alloantibody (inhibitor) against exogenous FVIII. Inhibitor development is currently the most significant treatment complication seen in patients with hemophilia and i...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3629762/ https://ncbi.nlm.nih.gov/pubmed/23610614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620712464509 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|